Progyny Statistics
Total Valuation
Progyny has a market cap or net worth of $1.30 billion. The enterprise value is $1.02 billion.
| Market Cap | 1.30B |
| Enterprise Value | 1.02B |
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Progyny has 78.33 million shares outstanding. The number of shares has decreased by -5.85% in one year.
| Current Share Class | 78.33M |
| Shares Outstanding | 78.33M |
| Shares Change (YoY) | -5.85% |
| Shares Change (QoQ) | -0.84% |
| Owned by Insiders (%) | 1.96% |
| Owned by Institutions (%) | 103.91% |
| Float | 71.67M |
Valuation Ratios
The trailing PE ratio is 25.54 and the forward PE ratio is 8.78. Progyny's PEG ratio is 1.10.
| PE Ratio | 25.54 |
| Forward PE | 8.78 |
| PS Ratio | 1.01 |
| Forward PS | 0.93 |
| PB Ratio | 2.66 |
| P/TBV Ratio | 2.65 |
| P/FCF Ratio | 6.78 |
| P/OCF Ratio | 6.19 |
| PEG Ratio | 1.10 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.39, with an EV/FCF ratio of 5.31.
| EV / Earnings | 17.39 |
| EV / Sales | 0.79 |
| EV / EBITDA | 10.39 |
| EV / EBIT | 10.95 |
| EV / FCF | 5.31 |
Financial Position
The company has a current ratio of 2.73, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.73 |
| Quick Ratio | 2.62 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.27 |
| Debt / FCF | 0.14 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.48% and return on invested capital (ROIC) is 23.92%.
| Return on Equity (ROE) | 12.48% |
| Return on Assets (ROA) | 8.61% |
| Return on Invested Capital (ROIC) | 23.92% |
| Return on Capital Employed (ROCE) | 17.22% |
| Weighted Average Cost of Capital (WACC) | 9.59% |
| Revenue Per Employee | $1.51M |
| Profits Per Employee | $68,364 |
| Employee Count | 856 |
| Asset Turnover | 1.91 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Progyny has paid $36.91 million in taxes.
| Income Tax | 36.91M |
| Effective Tax Rate | 38.68% |
Stock Price Statistics
The stock price has decreased by -28.11% in the last 52 weeks. The beta is 1.01, so Progyny's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | -28.11% |
| 50-Day Moving Average | 20.03 |
| 200-Day Moving Average | 22.30 |
| Relative Strength Index (RSI) | 28.32 |
| Average Volume (20 Days) | 1,382,217 |
Short Selling Information
The latest short interest is 5.63 million, so 7.19% of the outstanding shares have been sold short.
| Short Interest | 5.63M |
| Short Previous Month | 5.15M |
| Short % of Shares Out | 7.19% |
| Short % of Float | 7.86% |
| Short Ratio (days to cover) | 2.99 |
Income Statement
In the last 12 months, Progyny had revenue of $1.29 billion and earned $58.52 million in profits. Earnings per share was $0.65.
| Revenue | 1.29B |
| Gross Profit | 304.48M |
| Operating Income | 92.98M |
| Pretax Income | 95.43M |
| Net Income | 58.52M |
| EBITDA | 97.93M |
| EBIT | 92.98M |
| Earnings Per Share (EPS) | $0.65 |
Balance Sheet
The company has $310.10 million in cash and $27.73 million in debt, with a net cash position of $282.37 million or $3.60 per share.
| Cash & Cash Equivalents | 310.10M |
| Total Debt | 27.73M |
| Net Cash | 282.37M |
| Net Cash Per Share | $3.60 |
| Equity (Book Value) | 516.04M |
| Book Value Per Share | 6.24 |
| Working Capital | 349.38M |
Cash Flow
In the last 12 months, operating cash flow was $210.19 million and capital expenditures -$18.41 million, giving a free cash flow of $191.78 million.
| Operating Cash Flow | 210.19M |
| Capital Expenditures | -18.41M |
| Depreciation & Amortization | 4.95M |
| Net Borrowing | n/a |
| Free Cash Flow | 191.78M |
| FCF Per Share | $2.45 |
Margins
Gross margin is 23.63%, with operating and profit margins of 7.22% and 4.54%.
| Gross Margin | 23.63% |
| Operating Margin | 7.22% |
| Pretax Margin | 7.41% |
| Profit Margin | 4.54% |
| EBITDA Margin | 7.60% |
| EBIT Margin | 7.22% |
| FCF Margin | 14.88% |
Dividends & Yields
Progyny does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.85% |
| Shareholder Yield | 5.85% |
| Earnings Yield | 4.50% |
| FCF Yield | 14.75% |
Analyst Forecast
The average price target for Progyny is $26.50, which is 59.64% higher than the current price. The consensus rating is "Buy".
| Price Target | $26.50 |
| Price Target Difference | 59.64% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 5.92% |
| EPS Growth Forecast (5Y) | 27.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Progyny has an Altman Z-Score of 8.17 and a Piotroski F-Score of 6.
| Altman Z-Score | 8.17 |
| Piotroski F-Score | 6 |